ModelEdge

TherapeuticsMD
TXMD
Filing Type10-K
Filing Date3/29/2026
Updated3/30/26, 3:43 PM

Filing

10-K
Earnings Release

Exhibits

10-KFY 2025
EX-3.3COMPOSITE AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THE COMPANY, AS AMENDED
EX-3.11CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION, FILED IN THE STATE OF NEVADA, DATED JANUARY 5, 2026
EX-21.1SUBSIDIARIES OF THE COMPANY
EX-23.1CONSENT OF BERKOWITZ POLLACK BRANT
EX-23.2CONSENT OF CARR, RIGGS & INGRAM, L.L.C.
EX-31.1CERTIFICATION
EX-31.2CERTIFICATION
EX-32.1CERTIFICATION
EX-32.2CERTIFICATION
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic